Session: Clinically Realized Drug Delivery Technologies (2012 Annual Meeting)

Description:

This session will highlight some of the drug delivery technologies which, after originating in academic laboratories, have reached the clinic or are close to it. Talks in the session will present an overview of innovative technologies as well as the challenges faced while taking them to the clinic.

Sponsor:

Biomedical Applications of Chemical Engineering

Co-Sponsor(s):

Engineering Fundamentals in Life Science (15d)

Chair:

Samir Mitragotri
University of California, Santa Barbara
Chemical Engineering and Biomedical Engineering
Dept. of Chemical Engineering
Santa Barbara, CA 93106
Fax Number: 805-893-4731
Email: samir@engr.ucsb.edu

Co-Chair:

Steven Little
Assistant Professor
University of Pittsburgh
Chemical Engineering
1237 Benedum Hall
Pittsburgh, PA 15261
Email: srlittle@pitt.edu

Papers:

Introductory Remarks

60a

Nanoparticle Cancer Therapeutics: Concept to Clinic
Mark E. Davis, California Institute of Technology

60b

Multi-Reservoir Drug Therapies…From Academic Lab to Startup Company to Clinical Demonstration
John T. Santini Jr., On Demand Therapeutics, Inc.

60c

Graybug: Innovation in Ocular Drug Delivery
Justin Hanes, GrayBug

60d

Transdermal Drug Delivery: Translation From Chemical Engineering Laboratories Into the Clinic
Samir Mitragotri, University of California, Santa Barbara

60e

New Approaches to Treating Brain Tumors
Gary Gallia, Johns Hopkins Univ. SOM; Betty Tyler, Johns Hopkins University SOM; Henry Brem, Johns Hopkins University

See more of this Group/Topical: Topical 7: Biomedical Applications of Chemical Engineering

<< Previous Session | Next Session >>